APO RESEARCH · REPORT
Epinephrine
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
Product & engineering
Understand the product.
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.
Selected research
Market Structure
Global Epinephrine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.
Global Epinephrine key players include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, etc. Global top five manufacturers hold a share about 60%. USA is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Epinephrine Auto-injector is the largest segment, with a share about 60%. And in terms of application, the largest application is Anaphylaxis, followed by Cardiac Arrest, etc.
Read the full market overview
This report provides an overview of the global Epinephrine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Epinephrine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Epinephrine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Epinephrine market size, projected growth trends, production technologies, key applications, and end-use industries.
Epinephrine Segment by Company
Mylan Inc
Impax
ALK Abello
Lincoln Medical
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao
Epinephrine Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Epinephrine Segment by Application
Anaphylaxis
Cardiac Arrest
Others
Epinephrine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epinephrine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epinephrine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epinephrine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Epinephrine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epinephrine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Epinephrine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Epinephrine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Epinephrine Auto-injector
- Epinephrine Prefilled Syringe
- Combination Epinephrine Products
Applications
- Anaphylaxis
- Cardiac Arrest
- Others
Companies covered
- Mylan Inc
- Impax
- ALK Abello
- Lincoln Medical
- Pfizer
- Amphastar
- Emerade
- Grand Pharma
- Harvest Pharmaceuticals
- Merit Pharmaceutical
- Tianjin Jinyao
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Epinephrine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Epinephrine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Epinephrine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Epinephrine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Epinephrine Market Dynamics
- 2.1 Epinephrine Industry Trends
- 2.2 Epinephrine Industry Drivers
- 2.3 Epinephrine Industry Opportunities and Challenges
- 2.4 Epinephrine Industry Restraints
3 Epinephrine Market by Manufacturers
- 3.1 Global Epinephrine Revenue by Manufacturers (2021-2026)
- 3.2 Global Epinephrine Sales by Manufacturers (2021-2026)
- 3.3 Global Epinephrine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Epinephrine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Epinephrine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Epinephrine Manufacturers, Product Type & Application
- 3.7 Global Epinephrine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Epinephrine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Epinephrine Players Market Share by Revenue in 2025
- 3.8.3 2025 Epinephrine Tier 1, Tier 2, and Tier 3
4 Epinephrine Market by Type
- 4.1 Epinephrine Type Introduction
- 4.1.1 Epinephrine Auto-injector
- 4.1.2 Epinephrine Prefilled Syringe
- 4.1.3 Combination Epinephrine Products
- 4.2 Global Epinephrine Sales by Type
- 4.2.1 Global Epinephrine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Epinephrine Sales by Type (2021-2032)
- 4.2.3 Global Epinephrine Sales Market Share by Type (2021-2032)
- 4.3 Global Epinephrine Revenue by Type
- 4.3.1 Global Epinephrine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Epinephrine Revenue by Type (2021-2032)
- 4.3.3 Global Epinephrine Revenue Market Share by Type (2021-2032)
5 Epinephrine Market by Application
- 5.1 Epinephrine Application Introduction
- 5.1.1 Anaphylaxis
- 5.1.2 Cardiac Arrest
- 5.1.3 Others
- 5.2 Global Epinephrine Sales by Application
- 5.2.1 Global Epinephrine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Epinephrine Sales by Application (2021-2032)
- 5.2.3 Global Epinephrine Sales Market Share by Application (2021-2032)
- 5.3 Global Epinephrine Revenue by Application
- 5.3.1 Global Epinephrine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Epinephrine Revenue by Application (2021-2032)
- 5.3.3 Global Epinephrine Revenue Market Share by Application (2021-2032)
6 Global Epinephrine Sales by Region
- 6.1 Global Epinephrine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Epinephrine Sales by Region (2021-2032)
- 6.2.1 Global Epinephrine Sales by Region (2021-2026)
- 6.2.2 Global Epinephrine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Epinephrine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Epinephrine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Epinephrine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Epinephrine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Epinephrine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Epinephrine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Epinephrine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Epinephrine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Epinephrine Revenue by Region
- 7.1 Global Epinephrine Revenue by Region
- 7.1.1 Global Epinephrine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Epinephrine Revenue by Region (2021-2026)
- 7.1.3 Global Epinephrine Revenue by Region (2027-2032)
- 7.1.4 Global Epinephrine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Epinephrine Revenue (2021-2032)
- 7.2.2 North America Epinephrine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Epinephrine Revenue (2021-2032)
- 7.3.2 Europe Epinephrine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Epinephrine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Epinephrine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Epinephrine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Epinephrine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Mylan Inc
- 8.1.1 Mylan Inc Company Information
- 8.1.2 Mylan Inc Business Overview
- 8.1.3 Mylan Inc Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Mylan Inc Epinephrine Product Portfolio
- 8.1.5 Mylan Inc Recent Developments
- 8.2 Impax
- 8.2.1 Impax Company Information
- 8.2.2 Impax Business Overview
- 8.2.3 Impax Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Impax Epinephrine Product Portfolio
- 8.2.5 Impax Recent Developments
- 8.3 ALK Abello
- 8.3.1 ALK Abello Company Information
- 8.3.2 ALK Abello Business Overview
- 8.3.3 ALK Abello Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ALK Abello Epinephrine Product Portfolio
- 8.3.5 ALK Abello Recent Developments
- 8.4 Lincoln Medical
- 8.4.1 Lincoln Medical Company Information
- 8.4.2 Lincoln Medical Business Overview
- 8.4.3 Lincoln Medical Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lincoln Medical Epinephrine Product Portfolio
- 8.4.5 Lincoln Medical Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Epinephrine Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 Amphastar
- 8.6.1 Amphastar Company Information
- 8.6.2 Amphastar Business Overview
- 8.6.3 Amphastar Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Amphastar Epinephrine Product Portfolio
- 8.6.5 Amphastar Recent Developments
- 8.7 Emerade
- 8.7.1 Emerade Company Information
- 8.7.2 Emerade Business Overview
- 8.7.3 Emerade Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Emerade Epinephrine Product Portfolio
- 8.7.5 Emerade Recent Developments
- 8.8 Grand Pharma
- 8.8.1 Grand Pharma Company Information
- 8.8.2 Grand Pharma Business Overview
- 8.8.3 Grand Pharma Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Grand Pharma Epinephrine Product Portfolio
- 8.8.5 Grand Pharma Recent Developments
- 8.9 Harvest Pharmaceuticals
- 8.9.1 Harvest Pharmaceuticals Company Information
- 8.9.2 Harvest Pharmaceuticals Business Overview
- 8.9.3 Harvest Pharmaceuticals Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Harvest Pharmaceuticals Epinephrine Product Portfolio
- 8.9.5 Harvest Pharmaceuticals Recent Developments
- 8.10 Merit Pharmaceutical
- 8.10.1 Merit Pharmaceutical Company Information
- 8.10.2 Merit Pharmaceutical Business Overview
- 8.10.3 Merit Pharmaceutical Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Merit Pharmaceutical Epinephrine Product Portfolio
- 8.10.5 Merit Pharmaceutical Recent Developments
- 8.11 Tianjin Jinyao
- 8.11.1 Tianjin Jinyao Company Information
- 8.11.2 Tianjin Jinyao Business Overview
- 8.11.3 Tianjin Jinyao Epinephrine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Tianjin Jinyao Epinephrine Product Portfolio
- 8.11.5 Tianjin Jinyao Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Epinephrine Value Chain Analysis
- 9.1.1 Epinephrine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Epinephrine Production Mode & Process
- 9.2 Epinephrine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Epinephrine Distributors
- 9.2.3 Epinephrine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst